64: Why India's better placed to do a huge vaccine roll-out than most other countries, according to Dr Giridhar R Babu
The news about COVID-19 has shifted from daily death tolls and infection numbers to vaccine prospects. The Prime Minister is discussing rollout strategies and touring labs. Amidst the heated debate about the pros and cons of Oxford vs Moderna vs Pfizer vs Covaxin it’s easy to forget that the virus is still surging. Countries in the West are contemplating new stricter measures. In India, a new report claims that 3.4 million cases have been undercounted. The Supreme Court is rapping states on the knuckles, saying there’s a huge gap between government guidelines and what’s happening on the ground. Dr Giridhar Babu, head of life course epidemiology at the Public Health Foundation of India, joins Sandip to fill in some of these gaps between numbers and reality when it comes to COVID-19, vaccines and infections. And answer the all important question about when can the average Indian expect the vaccine. Tune in
